Abstract
There is an accumulating volume of research into neurological manifestations of coronavirus disease 2019 (COVID-19). However, inconsistent study designs, inadequate controls, poorly validated tests, and differing settings, interventions, and cultural norms weaken study quality and comparability, hence the understanding of the spectrum, burden, and pathophysiology of these complications. Therefore, a global COVID-19 Neuro Research Coalition, together with the World Health Organization, has reviewed reports of COVID-19 neurological complications and harmonized clinical measures for future research. This will facilitate well-designed studies using precise, consistent case definitions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and neurological complications, with standardized forms for pooled data analyses that nonspecialists can use, including those in low-income settings. ANN NEUROL 2021;89:1059–1067.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1059-1067 |
| Number of pages | 9 |
| Journal | Annals of neurology |
| Volume | 89 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2021 |
Funding
We would like to acknowledge the following organizations for their commitment to monitoring and understanding the neurological manifestations of COVID‐19: the European Academy of Neurology (EAN), the German Society of Neurology (DGN), the Global Consortium Study of Neurological Dysfunction in COVID‐19 (GCS‐NeuroCOVID), the CoroNerve Study Group, the Brain Infections Global COVID‐Neuro Network, the WHO Brain Health Unit with its Neuro‐COVID Global Forum, and the World Federation of Neurology (WFN). We also acknowledge the national registries of Italy, Spain, Germany, USA, and Mexico, with gratitude to their coordinators for providing us with their data collection structures. We also give special thanks to Professor Bernhard Hemmer, Department of Neurology, Technical University of Munich, for his ongoing support of the COVID‐19 Neuro Research Coalition, and to Erica Westenberg and Annette Abraham for coordinating the Coalition. ASW reports funding by the School of Medicine, Technical University of Munich, Grant Number H.40001.1.7‐08 in support of the global COVID‐19 Neuro Research Coalition. We would like to acknowledge the following organizations for their commitment to monitoring and understanding the neurological manifestations of COVID-19: the European Academy of Neurology (EAN), the German Society of Neurology (DGN), the Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID), the CoroNerve Study Group, the Brain Infections Global COVID-Neuro Network, the WHO Brain Health Unit with its Neuro-COVID Global Forum, and the World Federation of Neurology (WFN). We also acknowledge the national registries of Italy, Spain, Germany, USA, and Mexico, with gratitude to their coordinators for providing us with their data collection structures. We also give special thanks to Professor Bernhard Hemmer, Department of Neurology, Technical University of Munich, for his ongoing support of the COVID-19 Neuro Research Coalition, and to Erica Westenberg and Annette Abraham for coordinating the Coalition. ASW reports funding by the School of Medicine, Technical University of Munich, Grant Number H.40001.1.7-08 in support of the global COVID-19 Neuro Research Coalition.
ASJC Scopus subject areas
- Neurology
- Clinical Neurology